These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19851946)

  • 1. Risk messages about HPV, cervical cancer, and the HPV vaccine Gardasil: a content analysis of Canadian and U.S. national newspaper articles.
    Abdelmutti N; Hoffman-Goetz L
    Women Health; 2009; 49(5):422-40. PubMed ID: 19851946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk messages about HPV, cervical cancer, and the HPV vaccine gardasil in North American news magazines.
    Abdelmutti N; Hoffman-Goetz L
    J Cancer Educ; 2010 Sep; 25(3):451-6. PubMed ID: 20232189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A content analysis of news coverage of the HPV vaccine by U.S. newspapers, January 2002-June 2005.
    Calloway C; Jorgensen CM; Saraiya M; Tsui J
    J Womens Health (Larchmt); 2006 Sep; 15(7):803-9. PubMed ID: 16999634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diseases caused by human papilloma viruses].
    Zollner U; Schwarz TF
    Dtsch Med Wochenschr; 2011 May; 136(20):1067-72. PubMed ID: 21560109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current prophylactic HPV vaccines and gynecologic premalignancies.
    Harper DM
    Curr Opin Obstet Gynecol; 2009 Dec; 21(6):457-64. PubMed ID: 19923989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HPV vaccine: a content analysis of online news stories.
    Habel MA; Liddon N; Stryker JE
    J Womens Health (Larchmt); 2009 Mar; 18(3):401-7. PubMed ID: 19281323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giving Boys a Shot: The HPV Vaccine's Portrayal in Canadian Newspapers.
    Perez S; Fedoruk C; Shapiro GK; Rosberger Z
    Health Commun; 2016 Dec; 31(12):1527-38. PubMed ID: 27123533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV and HPV vaccine.
    Centers for Disease Control and Prevention
    J Med Assoc Ga; 2007; 96(1):45-7. PubMed ID: 17621907
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of women's knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines.
    Giles M; Garland S
    Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):311-5. PubMed ID: 16866792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination against human papilloma virus and cervical cancer].
    Kidon MI; Shechter E; Toubi E
    Harefuah; 2011 Jan; 150(1):33-6, 68. PubMed ID: 21449154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study.
    Rodriguez AM; Zeybek B; Vaughn M; Westra J; Kaul S; Montealegre JR; Lin YL; Kuo YF
    Cancer; 2020 Apr; 126(8):1656-1667. PubMed ID: 32037524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of preventive HPV vaccination.
    Roden R; Monie A; Wu TC
    Discov Med; 2006 Oct; 6(35):175-81. PubMed ID: 17234138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine.
    Ault KA; Joura EA; Kjaer SK; Iversen OE; Wheeler CM; Perez G; Brown DR; Koutsky LA; Garland SM; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Majewski S; Muñoz N; Sings HL; Harkins K; Rutkowski MA; Haupt RM; Garner EI;
    Int J Cancer; 2011 Mar; 128(6):1344-53. PubMed ID: 20949623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: the potential impact of different cross-protection profiles.
    Capri S; Gasparini R; Panatto D; Demarteau N
    Gynecol Oncol; 2011 Jun; 121(3):514-21. PubMed ID: 21334734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Currently approved prophylactic HPV vaccines.
    Harper DM
    Expert Rev Vaccines; 2009 Dec; 8(12):1663-79. PubMed ID: 19943762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus and vaccination in cervical cancer.
    Wang KL
    Taiwan J Obstet Gynecol; 2007 Dec; 46(4):352-62. PubMed ID: 18182340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the new HPV vaccines in clinical practice.
    Widdice LE; Kahn JA
    Cleve Clin J Med; 2006 Oct; 73(10):929-35. PubMed ID: 17044318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human papillomavirus (HPV) vaccines--a new method for the prevention of cervical cancer].
    Friedek DA; Ekiel AM; Martirosian G
    Wiad Lek; 2007; 60(1-2):34-8. PubMed ID: 17607966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
    J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine (GARDASIL) in Japanese women aged 18-26 years.
    Yoshikawa H; Ebihara K; Tanaka Y; Noda K
    Cancer Sci; 2013 Apr; 104(4):465-72. PubMed ID: 23331518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.